APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,984,261 | +61.4% | 50,770 | +64.4% | 0.03% | +44.4% |
| Q4 2023 | $1,848,537 | +591.1% | 30,881 | +339.2% | 0.02% | +350.0% |
| Q3 2023 | $267,459 | -88.6% | 7,031 | -72.7% | 0.00% | -88.6% |
| Q2 2023 | $2,349,925 | +63.5% | 25,795 | +18.4% | 0.04% | +45.8% |
| Q1 2023 | $1,437,598 | +9.7% | 21,795 | -14.0% | 0.02% | -7.7% |
| Q4 2022 | $1,310,745 | -40.0% | 25,348 | -20.7% | 0.03% | -43.5% |
| Q3 2022 | $2,184,000 | – | 31,975 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |